We are live on
!
Find out more
CCM
Carderock Capital Management Portfolio holdings
AUM
$456M
1-Year Est. Return
31.89%
This Fund
S&P 500
This Quarter
Est. Return
+3.19%
1 Year Est. Return
+31.89%
3 Year Est. Return
+88.65%
5 Year Est. Return
+111.4%
10 Year Est. Return
+513.53%
AUM
$200M
AUM Growth
+$10.8M
(+5.7%)
Cap. Flow
+$7.49M
Cap. Flow
% of AUM
3.75%
Top 10 Holdings %
Top 10 Hldgs %
28.07%
Holding
82
New
7
Increased
34
Reduced
30
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Labcorp
LH
|
+$2.9M |
| 2 |
CERN
Cerner Corp
CERN
|
+$2.81M |
| 3 |
Honeywell
HON
|
+$2.14M |
| 4 |
Costco
COST
|
+$2M |
| 5 |
Acuity Brands
AYI
|
+$1.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$3.01M |
| 2 |
NVO
Novo Nordisk
NVO
|
+$2.18M |
| 3 |
Danaher
DHR
|
+$1.41M |
| 4 |
Gilead Sciences
GILD
|
+$1.18M |
| 5 |
Novartis
NVS
|
+$994K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.8% |
| 2 | Healthcare | 22.33% |
| 3 | Industrials | 10.96% |
| 4 | Consumer Discretionary | 8.33% |
| 5 | Consumer Staples | 7.77% |
Similar funds
HFF
FIM
EGP
AWM
EIA
BRF
TCMP
FC
Carderock Capital Management's Q3 2016 Portfolio in Review
As of Q3 2016, Carderock Capital Management held 82 positions worth $200M, up 5.7% from $189M the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Carderock Capital Management deployed $7.49M of net new capital in Q3 2016, opening 7 new positions and adding to 34 existing holdings. Its largest new stake was Labcorp: 24,590 shares worth $2.9M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Stericycle Inc, an estimated $3.01M trimmed.
- Carderock Capital Management's largest Q3 2016 buy was Labcorp: 24,590 shares worth $2.9M.
- Carderock Capital Management added most to Honeywell in Q3 2016, an estimated $2.14M increase.
- Carderock Capital Management's biggest Q3 2016 reduction was Stericycle Inc, cutting an estimated $3.01M.
- Carderock Capital Management fully exited Gilead Sciences in Q3 2016, selling an estimated $1.18M.
- Carderock Capital Management's ten largest holdings make up 28% of its $200M portfolio in Q3 2016.
- Carderock Capital Management opened 7 new positions and closed 4 in Q3 2016.
- Carderock Capital Management's portfolio value rose 5.7% quarter-over-quarter to $200M.
Based on Carderock Capital Management's 13F filing for Q3 2016, filed 2 Nov 2016.